PhilippeFBackeljauwMD

PubMed

• Pediatric growth hormone deficiency: Understanding the patient and caregiver perspectives.
  Bradley S Miller, Harlan Tenenbaum, Sonia Di Carlo, Nicky Kelepouris, Philippe Backeljauw> ;Growth Hormone & IGF Research. 2024 Apr 16
• Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, a...
  Sandro Loche, Shankar Kanumakala, Philippe Backeljauw, Karl Otfried Schwab, Alfonso M Lechuga-Sancho, Altaher Esmael, Dragan Urosevic, Anca Boldea, Markus Zabransky> ;Drug Design, Development and Therapy. 2024 Jan 1
• Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth.
  Faith Lindsay Mart, Iris Gutmark-Little, Tara Streich-Tilles, Andrew T Trout, Jane Khoury, Katherine Bowers, Lori Casnellie, Philippe Backeljauw> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Feb 20
• 1 citations
  Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children With GH Deficiency.
  Rasmus J Kildemoes, Philippe F Backeljauw, Michael Højby, Joanne C Blair, Bradley S Miller, Jun Mori, Yassine K Lyauk> ;Journal of the Endocrine Society. 2023 Oct 9
• Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective.
  Philippe F Backeljauw, Mary Andrews, Peter Bang, Leo Dalle Molle, Cheri L Deal, Jamie Harvey, Shirley Langham, Elżbieta Petriczko, Michel Polak, Helen L Storr, Mehul T...> ;Orphanet Journal of Rare Diseases. 2023 Oct 7
• Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
  Gajanthan Muthuvel, Sareea Salem Al Remeithi, Corinne Foley, Andrew Dauber, Vivian Hwa, Philippe Backeljauw> ;Hormone Research in Paediatrics. 2024 Jan 1
• Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.
  Philippe Backeljauw, Joanne C Blair, Jean-Marc Ferran, Nicky Kelepouris, Bradley S Miller, Alberto Pietropoli, Michel Polak, Lars Sävendahl, Franciska Verlinde, Tilman...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Sep 18
• 1 citations
  Growth Hormone Deficiency Following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatri...
  Tamara L Wexler, Kent Reifschneider, Philippe Backeljauw, Javier F Cárdenas, Andrew R Hoffman, Bradley S Miller, Kevin C J Yuen> ;Journal of Neurotrauma. 2023 Jul 1
• 1 citations
  Abnormal Uterine Bleeding during Pubertal Induction with Transdermal Estrogen in Individuals with Turner Syndrome.
  Tara Streich-Tilles, Iris Gutmark-Little, Jessica Shafer, Lesley Breech, Lori Casnellie, Philippe Backeljauw, Shim, S., Yao, M.> ;Journal of Pediatric and Adolescent Gynecology. 2023 Aug 1
• 2 citations
  Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis.
  Judith Ross, Moshe Fridman, Nicky Kelepouris, Kristine Murray, Nils Krone, Michel Polak, Tilman R Rohrer, Alberto Pietropoli, Neil Lawrence, Philippe Backeljauw> ;Journal of the Endocrine Society. 2023 Mar 6
• 1 citations
  Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With-Related Overgrowth Spectrum.
  Nat Nasomyont, Meilan M Rutter, Philippe F Backeljauw> ;JCEM Case Reports. 2023 Mar 1
• Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study.
  Anders Juul, Philippe Backeljauw, Michael Højby, Masanobu Kawai, Rasmus Juul Kildemoes, Agnès Linglart, Nehama Zuckerman-Levin, Reiko Horikawa> ;European Journal of Endocrinology. 2023 Jan 10
• Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency.
  Gajanthan Muthuvel, Andrew Dauber, Eirene Alexandrou, Leah Tyzinski, Melissa Andrew, Vivian Hwa, Philippe Backeljauw> ;Hormone Research in Paediatrics. 2023 Jan 1
• 1 citations
  Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age.
  Anders Juul, Philippe Backeljauw, Marco Cappa, Alberto Pietropoli, Nicky Kelepouris, Agnès Linglart, Roland Pfäffle, Mitchell Geffner> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Apr 13
• 1 citations
  Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty.
  Marcela Vargas Trujillo, Peter A Lee, Kent Reifschneider, Philippe F Backeljauw, Sanja Dragnic, Stephen Van Komen, Jun Yu, Karen O Klein> ;Journal of Pediatric Endocrinology & Metabolism. 2023 Mar 28
• 1 citations
  Safety and effectiveness of Omnitrope(somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data.
  Philippe Backeljauw, Shankar Kanumakala, Sandro Loche, Karl Otfried Schwab, Bradley S Miller, Richard Levy, Kenneth McCormick, Hichem Zouater, Markus Zabransky, Kim Ca...> ;European Journal of Pediatrics. 2022 Jun 1
• 5 citations
  Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response.
  Gajanthan Muthuvel, Andrew Dauber, Eirene Alexandrou, Leah Tyzinski, Melissa Andrew, Vivian Hwa, Philippe Backeljauw> ;The Journal of Clinical Endocrinology and Metabolism. 2022 Apr 19
• 1 citations
  Clinical phenotype and musculoskeletal characteristics of patients with aggrecan deficiency.
  Eirene Alexandrou, Andrew Dauber, Leah Tyzinski, Vivian Hwa, Melissa Andrew, Hee Kim, Stacey Elangovan, Paul Gubanich, Jeffery A Taylor-Haas, Mark Paterno, Philippe Ba...> ;American Journal of Medical Genetics. Part A. 2022 Apr 1
• 3 citations
  Improving Anxiety Screening in Patients with Turner Syndrome.
  Eirene Alexandrou, Sarah Corathers, Iris Gutmark-Little, Lori Casnellie, Melissa Gerstle, Jonathan Tatum, Jane Khoury, Philippe Backeljauw> ;Hormone Research in Paediatrics. 2022 Jan 1
• 4 citations
  Genetic conditions of short stature: A review of three classic examples.
  Merlin G Butler, Bradley S Miller, Alicia Romano, Judith Ross, M Jennifer Abuzzahab, Philippe Backeljauw, Vaneeta Bamba, Amrit Bhangoo, Nelly Mauras, Mitchell Geffner> ;Frontiers in Endocrinology. 2022 Jan 1
• 10 citations
  Evolution and future of growth plate therapeutics.
  David B. Allen, Nadia Merchant, Bradley S. Miller, Philippe F. Backeljauw> ;Hormone Research in Paediatrics. 2021 Nov 10
• 4 citations
  Increased prevalence of β-cell dysfunction despite normal HbA1c in youth and young adults with Turner Syndrome.
  Nicole M. Sheanon, Deborah A. Elder, Jane Khoury, Lori Casnellie, Iris Gutmark-Little, Joseph T. Cernich, Philippe F. Backeljauw> ;Hormone Research in Paediatrics. 2021 Oct 15
• 11 citations
  Age at and indication for diagnosis of Turner syndrome in the pediatric population.
  Sarah Swauger, Philippe Backeljauw, Lindsey Hornung, Jessica Shafer, Lori Casnellie, Iris Gutmark-Little> ;American Journal of Medical Genetics. Part A. 2021 Aug 13
• 4 citations
  Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.
  Philippe Backeljauw, Shankar Kanumakala, Sandro Loche, Karl Otfried Schwab, Roland Pfäffle, Charlotte Höybye, Elena Lundberg, Tadej Battelino, Berit Kriström, Tomasz G...> ;Hormone Research in Paediatrics. 2021 Jan 1
• 24 citations
  Impact of short stature on quality of life: A systematic literature review.
  Philippe Backeljauw, Marco Cappa, Wieland Kiess, Lisa Law, Charlotte Cookson, Caroline Sert, John D Whalen, Mehul T. Dattani> ;Growth Hormone & IGF Research. 2021 Apr 1
• Join now to see all

Journal Articles

• Response to Letter to the Editor: Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic children with short stature  
  Sisley S, Backeljauw PF, J Pediatr, 11/1/2013
• The recommended dose for IGF-I therapy does not compromise long-term growth (Letter to the editor)  
  Backeljauw PF, Kuntze J, Frane J, Calicoglu A, Chernausek SD, J Clin Endocrinol Metab, 7/18/2013
• Cardiac magnetic resonance imaging in Turner syndrome  
  Gutmark-Little I, Backeljauw P, Clinical Endocrinology, 1/1/2013
• The impact of aortic arch geometry on flow characteristics  
  Prahl Wittberg L, van Wyk S, Mihaescu M, Fuchs, L, Gutmark E, Backeljauw P, Gutmark-Little I, American Institute of Aeronautics and Astronautics, 51st AIAA Aerospace Sciences Meeting Proceedings, 1/1/2013
• Adult height in patients with severe primary IGF-I deficiency  
  Backeljauw PF, Chernausek SD, Calicoglu A, Kuntze J, Frane J, Horm Res Paediatr, 1/1/2013
• Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic children with short stature  
  Sisley S, Vargas-Trujillo M, Khoury J, Backeljauw PF, J Pediatr, 1/1/2013
• The insulin-like growth factors and growth disorders of childhood  
  Backeljauw PF, Chernausek SD, Endocrinol Metab Clin N Am, 1/1/2012
• Identification and management of poor response to growth-promoting therapy in children with short stature  
  Bang P, Ahmed F, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO, Clinical Endocrinology, 1/1/2012
• Partial anomalous pulmonary venous return is common in Turner syndrome  
  Gutmark-Little I, Hor K, Gottliebson W, Cnota J, Gottliebson WM, Backeljauw PF, J Pediatr Endocr and Met, 1/1/2012
• Cardiovascular Anomalies in Turner Syndrome: Spectrum, Prevalence, and Cardiac MRI Findings in a Pediatric and Young Adult Population  
  Hee Kyung Kim, William Gottliebson, Kan Hor, Philippe Backeljauw, Iris Gutmark-Little, Shelia R. Salisbury, Judy M. Racadio, Kathy Helton-Skally, and Robert Fleck, Am. J. Roentgenol, 1/1/2011
• Non-classic congenital adrenal hyperplasia Clinical experience versus clinical guidelines  
  Shah AS, Backeljauw PF, Endocrinology Studies, 1/1/2011
• Superior mesenteric artery syndrome as a presentation of Graves' disease in adolescence  
  Howell JC, Cafasso M, Backeljauw PF, Endotrends, 1/1/2011
• Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial  
  Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM; MS301 Study Group. Abdullatif H, Allen H, Backeljauw P, Banks R, Bloch C, et al, J Clin Endocrinol Metab, 2/1/2010
• Insulin-like growth factor-I (IGF-I) in growth and metabolism  
  Backeljauw P, Bang P, Dunger DB, Juul A, Le Bouc Y, Rosenfeld R, J Ped Endocrinol Metab, 1/1/2010
• Endocrine sequelae of traumatic brain injury in children  
  Kaulfers AM, Backeljauw PF, Reifschneider K, Blum S, Michaud L, Weiss M, Rose SR, J Pediatr, 1/1/2010
• Dental development in children with growth hormone insensitivity syndrome: Demirjian analysis of serial panoramic radiographs  
  Campbell R, Weinshel R, Backeljauw P, Wilson S, Bean J, Shao M, Cleft Palate-Craniofacial Journal, 1/1/2009
• Puberty in Turner syndrome  
  Backeljauw P, Highlights, 1/1/2009
• Treatment of severe IGF-I deficiency with recombinant human IGF-I (mecasermin)  
  Backeljauw PF, Chernausek SD, Growth-Growth hormone, IGF-1, and Metabolism, 1/1/2009
• Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas  
  Lomenick JP, Reifschneider KL, Lucky AW, Woo JG, Backeljauw PF, Archives in Dermatology, 1/1/2009
• Allergic reaction to mecasermin, recombinant human insulin-like growth factor-I  
  Allred Metz K, Assa'ad A, Lierl MB, Backeljauw P, Ann Allergy, Asthma & Clin Immunol, 1/1/2009
• Does growth hormone therapy before 4 years of age enhance the linear growth in girls with Turner's syndrome?  
  Philippe F. Backeljauw, Nat Clin Pract Endocrinol Metab, 1/1/2008
• Clinical Diagnosis of IGF-I deficiency Part I of: treatment perspectives in idiopathic short stature with a focus on IGF-1 deficiency  
  Rosenthal S, Cohen P,Clayton P, Backeljauw P, Bang P, Ten S, Rosenfeld R, Pediatr Endocrinol Rev, 1/1/2007
• Defining and managing growth hormone treatment failure Part II of: treatment perspectives in idiopathic short stature with a focus on IGF-1 deficiency  
  Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S, Rosenfeld R, Pediatr Endocrinol Rev, 1/1/2007
• Algorithms for the evaluation and management of short stature Part III of: treatment perspectives in idiopathic short stature with a focus on IGF-1 deficiency  
  Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S, Rosenfeld R, Pediatr Endocrinol Rev, 1/1/2007
• Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants treated with hemangiomas-a retrospective study  
  Jefferson P. Lomenick, Philippe F. Backeljauw, Ann W. Lucky, Pediatr Dermatol, 1/1/2006
• Join now to see all

Books/Book Chapters

• Pediatric Endocrinology 
  Chapter: Disorders of growth hormone/insulin-like growth factor secretion and action 
  Page 292 - 404Backkeljauw PF, Dattani MT, Cohen P, Rosenfeld RGEditors: Sperling MA.Elsevier-Saunders, PhiliadelphiaEdition 4,2014
• Pediatric Endocrinology: A Practical Clinical Guide 
  Chapter: Turner syndrome. 
  Page 109 - 136Davenport M, Ross J, Backeljauw PEditors: Sally Radovick, Margaret H. MacGillivray.Humana Press, New YorkEdition 2nd,2013
• The 5 Minute OB/GYN Consult 
  Chapter: Turner syndrome. 
  Page 186 - 187Philippe F. BackeljauwEditors: Adams Hillard, PJ.Lippincott Williams & Wilkins, PhiladelphiaEdition 1st,2008
• Educational booklet of The Human Growth Foundation 
  Chapter: Insulin-like growth factor I deficiency. 
  Philippe BackeljauwThe Human Growth Foundation, Inc.2008
• A Current Review of Pediatric Endocrinology 
  Chapter: Hypercalcemia. 
  Page 155 - 162Philippe BackeljauwBiosymposia, Inc.2007
• Central and Peripheral Mechanisms in Pituitary Disease 
  Chapter: Growth hormone resistance as a model for understanding IGF-I actions. 
  Page 43 - 52L Underwood, P Backeljauw and the GHIS Collaborative GroupEditors: Kleinberg DL and Clemmons DR.BioScientifica Ltd, Bristol2002
• The 5 Minute Pediatric Consult 
  Chapter: Short stature. 
  Page 48 - 49Philippe F. BackeljauwEditors: Schwartz MW.Williams & Wilkins, BaltimoreEdition 1st,1996
• Join now to see all

Abstracts/Posters

• SNP Microarray analysis reveals whole gene deletion of the mineralocorticoid receptor in a patient with features of pseudohypoaldosteronism type 1.
  Dyer L, Wasserman H, Backeljauw P, MD, Smolarek T, Journal of Molecular Diagnostics; Annual Meeting of the Association for Molecular Pathology, Phoenix, AZ, 11/1/2013
• Recombinant human insulin-like growth factor-I (IGF-I) in Duchenne Muscular Dystrophy (DMD).
  Rutter MM, Collins J, Wong B, Horn P, Taylor MD, Hu S, Blum S, Morehart P, Sawnani H, Backeljauw PF, 18th International WMS Congress, Asilomar, CA, 10/1/2013
• Height predictions using ulna length are inaccurate in glucocorticoid-treated boys with Duchenne Muscular Dystrophy (DMD).
  Meilan M Rutter, James Collins, Hemant Sawnani, Paul Horn, Philippe F Backeljauw, Samantha Blum, Shengyong Hu, Paula Morehart, Michael D Taylor, Brenda Wong, 18th International WMS Congress, Asilomar, CA, 10/1/2013
• Safety results from a phase II, randomized, open-label, active-controlled trial of rhGH/rhIGF-1 combination therapy in children with short Stature, low IGF-1 and GH su...
  Miller B, Backeljauw P, Dutailly P, Sicsic A, Lawson E, Hale D, Reiner B, Sperling M, 95th Annual Meeting of the Endocrine Society, San Francisco, CA, 6/1/2013
• Aortic blood flow characteristics in Turner syndrome.
  Gutmark-Little I, Prahl Wittberg L, van Wyk S, Backeljauw PF, 95th Annual Meeting of the Endocrine Society, San Francisco, CA, 6/1/2013
• Characteristics of the flow in the aortic arch.
  Prahl-Wittberg L, van Wyk S, Mihaescu M, Fuchs L, Gutmark EJ, Backeljauw P, Gutmark-Little I, 51st AIAA Aerospace Sciences Meeting, Grapevine, TX, 1/1/2013
• Efficacy of rhGH/rhIGF-1 co-administration therapy in children with short stature, low IGF-1 and GH sufficiency-results from a phase II, randomized, open-label, active...
  Backeljauw P, Miller B, Dutailly P, Sicsic A, Lawson E, Hale D, Reiner B, Sperling M, Horm Res; 9th Joint Meeting of Pediatric Endocrinology, Milan, Italy, September 2013, 1/1/2013
• Recombinant human insulin-like growth factor-I (IGF-I) in Duchenne Muscular Dystrophy (DMD).
  Rutter MM, Collins J, Wong B, Horn P, Taylor MD, Hu S, Blum S, Morehart P, Sawnani H, Backeljauw PF, Horm Res; 9th Joint Meeting of Pediatric Endocrinology, Milan, Italy, September 2013, 1/1/2013
• Liver function test abnormalities begin early in life in Turner syndrome.
  Jimenez-Vega JM, Backeljauw P, Khoury J, Lawson S, Gutmark-Little I, Horm Res; 9th Joint Meeting of Pediatric Endocrinology, Milan, Italy, September 2013, 1/1/2013
• Efficacy and cost-effectiveness of laboratory screening in short stature.
  Sisley S, Vargas M, Backeljauw PF, The 94th Annual Meeting of the Endocrine Society, Houston, TX, 6/1/2012
• Oophorectomy versus salpingo-oophorectomy in Turner syndrome patients with Y-chromosome material: current practice patterns assessment.
  Shankar RK, Inge T, Backeljauw PF, The 94th Annual Meeting of the Endocrine Society, Houston, TX, 6/1/2012
• Vasculopathy in the young Turner syndrome population.
  Lawson S, Urbina E, Khoury P, Gutmark-Little I, Backeljauw P, Meeting on Strategies To Improve Care Outcome In Turner syndrome, Winthrop University Hospital, 9/1/2011
• Vasculopathy in the young Turner syndrome population.
  Lawson S, Urbina E, Khoury P, Sucharew H, Gao Z, Backeljauw B, Gutmark-Little I, Backeljauw P, Annual PAS/PES/SPR Joint Meeting, Denver, CO, 5/1/2011
• Computational airway modeling: a novel method to analyze airway anomalies in Turner syndrome (TS).
  Gutmark-Little I, Mylavarapu G, Mihaescu M, Gutmark E, Backeljauw P, Annual PAS/PES/SPR Joint Meeting, Denver, CO, 5/1/2011
• Long-term treatment with recombinant human IGF-I: Results in patients with primary IGF-I deficiency.
  Backeljauw P, International Symposium on GH, IGF-I, Ghrelin/GHS: Climbing The Scientific Growth Ladder, Orlando, FL, 3/1/2011
• Danazol therapy-induced central precocious puberty in a patient with hereditary angioedema.
  Auble B, Backeljauw P, 93rd Annual Meeting of the Endocrine Society, Boston, MA, 1/1/2011
• Craniofacial growth with insulin-like growth factor-I therapy in children with severe primary IGF-I deficiency.
  Backeljauw P, Campbell R, Annual PAS/LWPES/SPR Joint Meeting, Vancouver, 5/1/2010
• Turner syndrome aortopathy demonstrated by cardiac MRI-determined pulse wave velocity (PWV).
  Hagenbuch S, Hor K, Mazur W, Fleck R, Backeljauw P, Benson DW, Gotttliebson W, Wansapura J, Annual Meeting of the American College of Cardiology, Atlanta, GA, 3/1/2010
• Efficacy and safety of intranasal desmopressin acetate administered orally for the management of infants with neurogenic diabetes insipidus (DI).
  Gutmark-Little I, Repaske D, Backeljauw P, 92nd Annual Meeting of the Endocrine Society, San Diego, CA, 1/1/2010
• Twenty years of efficacy and safety information with recombinant human IGF-I therapy: how will our clinical experience alter the approach to the treatment of short sta...
  Backeljauw P, GH & IGF-I Research, 1/1/2010
• Partial anomalous pulmonary venous return (PAPVR) in adolescent and young adult Turner syndrome (TS) patients: prevalence and hemodynamic significance as determined by...
  Iris Gutmark-Little, William Gottliebson, Kan Hor, James Cnota, Philippe Backeljauw, Horm Res, 1/1/2009
• Final and near-final adult height in patients with severe primary insulin-like growth factor-I deficiency (IGFD) after long-term treatment with recombinant human insul...
  Philippe F. Backeljauw, Ali S Calicoglu, Joyce Kuntze, James W Frane, Steven Chernausek, Horm Res, 1/1/2009
• Therapy with rhIGF-I for severe primary IGF-I deficiency-data analysis from the US IGFD Registry.
  Backeljauw P, Abstract Book for the ESPE Satellite Symposium, 9/1/2008
• Under-recognized prevalence of elevated blood pressure in girls with Turner syndrome.
  Gutmark-Little I, Woo JG, Backeljauw PF, Annual PAS/LWPES/SPR Joint Meeting, 5/1/2008
• Endocrine sequelae of traumatic brain injury in children.
  Kaulfers A, Blum S, Backeljauw P, Rose S, Annual PAS/LWPES/SPR Joint Meeting; EPAS, 5/1/2008
• Join now to see all

Lectures

• Pediatric Transgender Medicine, Growth Disorders, and Puberty 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Reproductive Issues and Fertility Preservation in Individuals with Turner Syndrome 
  ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
• Clinical guidelines for Turner syndrome care-revisited. 
  Jacksonville, FL - 7/14/2014
• The development of a Turner syndrome resource center-viewpoint from the health care provider. 
  Jacksonville, FL - 7/13/2014
• Co-chairman and moderator: Turner Syndrome Health and Wellness in the 21st Century: the Crossroads of Health Care Research and Health Care Delivery. 
  Jacksonville, FL - 7/13/2014
• Liver disease in Turner syndrome. 
  Jacksonville, FL - 7/12/2014
• An update on novel growth promoting therapies. 
  Chicago, IL - 3/22/2014
• Growth Hormone plus Insulin-Like Growth Factor-1 Co-Administration Therapy in Short Children with Low IGF-I and GH Sufficiency: Results from a Randomized, Multi-Center... 
  Birmingham, AL - 10/1/2013
• Co-chairman: Growth Disorders 1-guided poster tour. 
  Milan, Italy - 9/1/2013
• Chair: The Gland-Brain Connection: Hormones, Cognition, and Behavior. 
  Washington, DC - 5/1/2013
• Co-chairman: "Basic Growth Genetics for Clinicians" 
  Berlin, Germany - 2/1/2013
• Moderator: "Clinical cases seminar on IGF deficiency" 
  Berlin, Germany - 2/1/2013
• Co-chairman: "Online Genetic Resources for Clinicians" 
  Berlin, Germany - 2/1/2013
• Characteristics of the flow in the aortic arch. 
  Grapevine, TX - 1/1/2013
• Turner syndrome-update on cardiovascular research. 
  Children's Hospital of Fudan University, Shanghai, China - 11/1/2012
• When to stop GH: pathophysiological and management considerations for ending GH treatment in GH-deficient and Turner syndrome patients. 
  Leipzig, Germany - 9/1/2012
• Long-term results of IGF-I treatment in severe primary IGF-I deficiency-Adult and near-adult efficacy and safety data. 
  Houston, TX - 6/1/2012
• The incidence of pathology and cost of screening in the evaluation of children with short stature. 
  Houston, TX - 6/1/2012
• The diagnosis of short stature-A practical approach. 
  Philadelphia, PA - 5/1/2012
• The approach to the growth hormone deficient patient during the period of transitional care: current data, recommendations and guidelines. 
  Philadelphia, PA - 5/1/2012
• Adult and near-adult efficacy and safety data of long-term IGF-I therapy in children with IGF deficiency. 
  Chicago, IL - 3/1/2012
• Response to IGF-1 therapy in severe primary IGF-1 deficiency. 
  Stockholm, Sweden - 1/1/2012
• Grand Rounds: "An update on cardiovascular disease in Turner syndrome." 
  Rush University Medical Center, Chicago, IL - 10/1/2011
• Long-term results of IGF-1 treatment in severe primary IGF-1 deficiency. 
  Glasgow, Scotland - 9/1/2011
• An update on vasculopathy research in Turner syndrome. 
  Cincinnati, OH - 5/1/2011
• Join now to see all

Other

• Growth as a Clinical Barometer of Health in the Pediatric Patient. 
  Philippe Backeljauw, PV Updates, Peer Direct Publishing (Sponsored by Novo Nordisk, Inc.)
  1/1/2012
• PREP Endocrinology. 
  Philippe Backeljauw, Pediatrics Review and Education Program, American Academy of Pediatrics
  1/1/2012
• Growth Hormone Deficiency and Other Causes of Short Stature: Trends in Diagnosis, Evaluation, and Treatment in Children and Adults. 
  Mark A. Sperling, MD; David B. Allen, MD; Philippe F. Backeljauw, MD; Robert Rapaport, MD, Endocrine Today Education Lab
  http://www.Haelio.com
  1/1/2012
• Treating the IGF-1-Deficient Patient: Challenges and Solutions. (CME-approved educational activity.) 
  Philippe Backeljauw, Medscape, LLC
  1/1/2011
• Exploring first-line therapy options for growth failure. (CME-approved educational slide kit) 
  Philippe Backeljauw (chair), Ciccarelli C, Cohen J, Estrada E, Geffner M, Luetjen T, Miller K, Savage M, Medical Education Resources, Inc and Consensus Medical Communications
  1/1/2009
• IGF-I therapy of primary IGF-I deficiency: efficacy and safety considerations. 
  Philippe F Backeljauw
  http://www.IGFDForum.com
  1/1/2009
• Clinical debates on the treatment and management of patients with IGFD: How do we manage primary and secondary IGFD? 
  Philippe F. Backeljauw
  http://www.IGFDForum.com
  1/1/2008
• New areas for growth: diagnosis and treatment of IGF-I deficiency. 
  Philippe F. Backeljauw
  http://www.IGFDForum.com
  1/1/2006
• Join now to see all